Alerts will be sent to your verified email
Verify EmailTHYROCARE
Thyrocare Tech.
|
Krsnaa Diagnostics
|
Vimta Labs
|
|
---|---|---|---|
Operational Metrics
|
|||
Diagnostics
|
|||
Number of Daily Patients - Diagnostic Centres
|
45.75 Ths | 11.67 Ths | n/a |
Number of Samples - Quarterly
|
5.9 Million | n/a | n/a |
No of Tests - Quarterly
|
41.98 Mn | 5.42 Mn | n/a |
Financials
|
|||
5 yr Average ROE
|
21.92 % | 8.47 % | 12.51 % |
5yr average Equity Multiplier
|
1.35 | 1.32 | 1.33 |
5yr Average Asset Turnover Ratio
|
0.83 | 0.53 | 0.82 |
5yr Avg Net Profit Margin
|
19.57 % | 12.31 % | 11.37 % |
Price to Book
|
8.76 | 2.94 | 7.05 |
P/E
|
52.34 | 32.62 | 39.41 |
5yr Avg Cash Conversion Cycle
|
-5.15 Days | -95.52 Days | 122.88 Days |
Inventory Days
|
17.88 Days | 12.7 Days | 26.64 Days |
Days Receivable
|
41.03 Days | 73.45 Days | 95.75 Days |
Days Payable
|
51.63 Days | 332.62 Days | 315.03 Days |
5yr Average Interest Coverage Ratio
|
72.56 | 7.45 | 21.55 |
5yr Avg ROCE
|
28.32 % | 11.5 % | 16.46 % |
5yr Avg Operating Profit Margin
|
32.43 % | 25.75 % | 25.53 % |
5 yr average Debt to Equity
|
0.01 | 0.1 | 0.11 |
5yr CAGR Net Profit
|
-4.3 % | -3.63 % | 43.08 % |
5yr Average Return on Assets
|
16.06 % | 6.5 % | 9.62 % |
Shareholdings
|
|||
Promoter Holding
|
71.06 % | 27.24 % | 36.7 % |
Share Pledged by Promoters
|
100.0 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.12 % | -0.14 % | -0.76 % |
Change in Mutual Fund Holding (3 Yrs)
|
8.41 % | -1.2 % | -1.48 % |
Thyrocare Tech.
|
Krsnaa Diagnostics
|
Vimta Labs
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|
Capex
|
Capex
|
-
|
-
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
Pathology vs Radiology
|
Pathology vs Radiology
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|